Bpendo
Insufflation of the colon is required for visualization during colonoscopy. However, when air or fluid incontinence occurs, maneuverability and visualization are compromised. This issue costs valuable time, adds frustration for the physician and staff, may result in sub-optimal exam, earlier repeat colonoscopies, and increased costs. BPEndo’s, Insufflation Retention Device (IRD) is an add-on device that solves the problem of air or fluid incontinence by creating a seal in the rectum while simultaneously allowing full freedom of movement for the endoscope to ensure full visualization. The patented and FDA approved IRD essentially makes an incompetent sphincter competent. BPEndo recently closed a $3M Series A round for scaling manufacturing and commercialization. Our hope is to launch product in Q1 2025.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Bpendo
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
- RH
Robert Holbrook
Principal CEO · Other
EmailPhone
Showing 1 of 1 verified contacts
Top roles at Bpendo
1 distinct titles indexed · top 1 shown.
- 1principal ceo
Sign up to unlock all 1 contacts at Bpendo
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Bpendo
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.